Member access

4-Traders Homepage  >  Shares  >  Nyse  >  International Business Machines Corp.    IBM   US4592001014

Delayed Quote. Delayed Nyse - 03/26 04:02:08 pm
160.59 USD   +0.87%
01:36p BUSINESS MACHIN : National Health Service in England and Wales Selec..
12:52pDJMARKET SNAPSHOT : U.S. Stocks Pare Losses, Techs Rebound
12:46p DOW MOVERS : Csco, ibm
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales104 50799 75192 79385 32284 83086 299
Operating income (EBITDA)26 38326 14323 43723 40123 64125 183
Operating profit (EBIT)21 70721 46518 94519 21419 35320 840
Pre-Tax Profit (EBT)21 90219 524----
Net income16 60416 48312 02214 55014 75915 152
EPS ( $)14,414,911,914,915,617,7
Dividend per Share ( $)3,303,70-4,554,844,73
Yield2,07%2,32%-2,86%3,04%2,97%
Announcement Date01/22/2013
09:06pm
01/21/2014
09:05pm
01/20/2015
09:06pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt22 14028 65232 32830 95729 54430 246
Finance------
Operating income (EBITDA)26 38326 14323 43723 40123 64125 183
Leverage
(Debt/EBITDA)
0,84x1,10x1,38x1,32x1,25x1,20x
Capital Expenditure4 0823 7683 8004 2414 2154 381
Book Value Per Share (BVPS)16,9 $21,1 $12,0 $19,0 $25,2 $33,2 $
Cash Flow per Share17,0 $15,9 $16,7 $17,8 $18,8 $21,7 $
Announcement Date01/22/2013
09:06pm
01/21/2014
09:05pm
01/20/2015
09:06pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 157 357 M$ -
Entreprise Value (EV) 188 314 M$ 186 901 M$
Valuation 2015e 2016e
PER (Price / EPS) 10,7x 10,2x
Capitalization / Revenue 1,84x 1,85x
EV / Revenue 2,21x 2,20x
EV / EBITDA 8,05x 7,91x
Yield (DPS / Price) 2,86% 3,04%
Price to book (Price / BVPS) 8,38x 6,31x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 22,5% 22,8%
operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) 17,1% 17,4%
ROA (Net Profit / Asset) 12,7% 12,6%
ROE (Net Profit / Equities) 79,1% 66,4%
Rate of Dividend 30,7% 31,0%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   4,97% 4,97%
Cash Flow / Sales (Taux d'autofinancement) 20,6% 21,9%
Capital Intensity (Assets / Sales) 1,34x 1,38x
Financial Leverage (Net Debt / EBITDA) 1,32x 1,25x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF